CoChat

Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma

Open access
Hattori, Aritoshi, Hirayama, Shunki, Matsunaga, Takeshi, Hayashi, Takuo, Takamochi, Kazuya, Oh, Shiaki, Suzuki, Kenji · 2019 · Journal of Thoracic Oncology
Cited by 183

The DOI matches its Crossref record.

Abstract

Introduction: We evaluated differences in the clinicopathologic characteristics and prognosis based on the presence of ground glass opacity (GGO) components in small‐sized lung adenocarcinoma. Methods: We retrospectively investigated 634 lung adenocarcinomas classed as c‐stage IA in the eighth edition TNM classification. Staging was defined according to the solid component size measured by thin‐section computed tomography. All tumors were grouped into either a GGO or solid group, based on the presence of a GGO component. Results: Of the cases, 215 (34%) were classed as c‐stage IA1 (T1mi: 88, T1a‐GGO: 102, T1a‐solid: 25), 255 (40%) as c‐stage IA2 (T1b‐GGO: 122, T1b‐solid: 133), and 164 (26%) as c‐stage IA3 (T1c‐GGO: 44, T1c‐solid: 120). Among the 546 c‐stage IA cases excluding the T1mi lesions, Cox regression analysis revealed that presence of GGO was an independently significant prognosticator (p = 0.024). The result was validated in 494 c‐stage IA lung adenocarcinomas with a nonpredominant GGO component, showing the presence of GGO as a significant prognosticator (p = 0.048). When we evaluated the prognostic impact of GGO presence in each clinical stage, the 5‐year overall survival (OS) was significantly different between the GGO and solid groups (IA1: 97.8% versus 86.6%, p = 0.026; IA2: 89.3% versus 75.2%, p = 0.007; IA3: 88.5% versus 62.3%, p = 0.003). Furthermore, the 5‐year overall survival b was distinct in parallel similar pathologic findings when comparing a lepidic versus an invasive component (IA1: 97.9% versus 85.6%, p = 0.031; IA2: 86.1% versus 69.4%, p = 0.007; IA3: 77.5% versus 55.8%, p < 0.001). Conclusions: Clinicopathologic and oncologic outcomes were disparate based on the presence of a GGO component in the eighth edition TNM classification of c‐stage IA lung adenocarcinoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jtho.2018.09.026

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 183

Metadata

Authors
Hattori, A., Hirayama, S., Matsunaga, T., Hayashi, T., Takamochi, K., Oh, S., & Suzuki, K.
Venue
Journal of Thoracic Oncology
Publisher
Elsevier BV
Published
2019-02
Volume
14
Issue
2
Pages
265-275
ISSN
1556-0864 (ISSN-L)
OpenAlex
W2898278081
Cited by
183
References
0
FWCI
7.95
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma. https://app.cochat.ai/papers/10.1016/j.jtho.2018.09.026
The paper
Hattori, A., Hirayama, S., Matsunaga, T., Hayashi, T., Takamochi, K., Oh, S., & Suzuki, K. (2019). Distinct Clinicopathologic Characteristics and Prognosis Based on the Presence of Ground Glass Opacity Component in Clinical Stage IA Lung Adenocarcinoma. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2018.09.026

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.